Posted in | News | Nanoregulations

U.S. Federal Regulators Initiate Research Studies into Risks of Nanotechnology

Nanotechnology, which has widespread applications in various spheres such as electronics, food, health care products, personal products, pharmaceutical products and textiles has come under the scanner of the U.S. Food and Drug Administration which has planned to launch a series of studies into the possible risks involved in nanotechnology.

Noted environmental attorney and partner at Newark based Tort Defense Practice, James A. Kosch, has authored a column on this topic at the website www.CorporateComplianceInsights.com. Kosch, who appears to be in favor of the FDA’s move, highlights the aspects of the two regulatory guidelines released by the FDA in April 2012. The nonbinding guidelines propose further research into the effect of exposure to nano materials on the cells. This comprises toxicology tests at various levels of exposure, in vitro and in vivo studies and dermal penetration. In a move that is considered to be non-customary of Regulatory guidelines, the FDA has invited manufacturers and sellers of nano based products to volunteer information to aid the research.

Kosch states that the move should not be considered retrogressive but as an opportunity to eliminate the uncertainties clouding this technology. The properties of materials at nano sizes may differ significantly from those at macro sizes. Added to this is the confusion caused by contradictory proclamations from different quarters such as the potential harm caused by the use of nano scale titanium dioxide in sunscreens. There is also ambiguity over regulatory jurisdiction between the FDA and FIFRA [The Federal Insecticide, Fungicide and Rodenticide Act]particularly in the case of micro bodies released into the environment by nano particles. Cooperating with the Regulators is bound not to be detrimental but would in fact pave the way for advancement in nanotechnology.

Source: http://www.corporatecomplianceinsights.com

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 12). U.S. Federal Regulators Initiate Research Studies into Risks of Nanotechnology. AZoNano. Retrieved on April 18, 2024 from https://www.azonano.com/news.aspx?newsID=24897.

  • MLA

    Thomas, G.P.. "U.S. Federal Regulators Initiate Research Studies into Risks of Nanotechnology". AZoNano. 18 April 2024. <https://www.azonano.com/news.aspx?newsID=24897>.

  • Chicago

    Thomas, G.P.. "U.S. Federal Regulators Initiate Research Studies into Risks of Nanotechnology". AZoNano. https://www.azonano.com/news.aspx?newsID=24897. (accessed April 18, 2024).

  • Harvard

    Thomas, G.P.. 2019. U.S. Federal Regulators Initiate Research Studies into Risks of Nanotechnology. AZoNano, viewed 18 April 2024, https://www.azonano.com/news.aspx?newsID=24897.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.